UPDATE 2-FDA flags concerns at Akorn's Amityville plant, shares slip
February 28, 2019 at 11:56 AM EST
Generic drugmaker Akorn Inc said on Thursday the U.S. Food and Drug Administration had raised concerns about its manufacturing plant in Amityville, New York, that included a lack of records on the maintenance and cleaning of equipment.